Version 1.3, revision planned in 2012.
Last revised in April 2008
August 2009 — minor update. Advice from the National Institute for Clinical Excellence guideline on when to suspect child maltreatment has been added to this topic [NICE, 2009]. Issued in August 2009.
December 2008 — minor update to reflect guidance from the Health Protection Agency (HPA) to avoid broad spectrum antibiotics (e.g. co-amoxiclav, quinolones, and cephalosporins) when narrow spectrum antibiotics remain effective, as broad spectrum antibiotics increase the risk of Clostridium difficile, MRSA, and resistant UTIs [HPA and Association of Medical Microbiologists, 2008]. Issued in January 2009.
December 2007 to April 2008 — converted from PRODIGY guidance to CKS topic structure. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence.
The main changes to the recommendations for managing urinary tract infections in infants and children are:
- Duration of treatment of lower UTI/cystitis is 3 days.
- However, CKS recommends that nitrofurantoin be prescribed for 7 days as its licence specifies, and the NICE guideline does not specifically recommend prescribing outside the terms of the licence.
- Duration of treatment of upper UTI/acute pyelonephritis is 7–10 days.
In comparison with previously accepted good practice the NICE guidelines recommend considerably narrower indications for imaging investigations and long term prophylactic antibiotics following a UTI. However, as imaging investigations and prophylactic antibiotics would normally be arranged by (or after consultation with) a specialist, their indications are outside the scope of this CKS topic.